Inventor · disambiguated record
Henry Morrison
Also filed as: MORRISON HENRY · MORRISON HENRY G · MORRISON HENRY GRANT · MORRISON II HENRY GRANT
23 granted patents·12 pending applications·269 citations·filing 2002–2025
96Inventor score
Top patents by PatentIndex Score
35 records- 0196US11958809B2Salt of omecamtiv mecarbil and process for preparing saltCYTOKINETICS INC·Filed 2021·Granted Apr 16, 2024·10 cites·5 claims
- 0296US11472773B2Salt of omecamtiv mecarbil and process for preparing saltAMGEN INC·Filed 2020·Granted Oct 18, 2022·17 cites·20 claims
- 0396US6605729B1Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)WARNER LAMBERT CO·Filed 2002·Granted Aug 12, 2003·104 cites·15 claims
- 0494US12221417B2Salt of omecamtiv mecarbil and process for preparing saltCYTOKINETICS INC·Filed 2023·Granted Feb 11, 2025·2 cites·4 claims
- 0594US9988354B2Salt of omecamtiv mecarbil and process for preparing saltAMGEN INC·Filed 2014·Granted Jun 5, 2018·24 cites·7 claims
- 0693US11465969B2Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2019·Granted Oct 11, 2022·16 cites·32 claims
- 0793US11396509B2Solid forms of a toll-like receptor modulatorGILEAD SCIENCES INC·Filed 2020·Granted Jul 26, 2022·6 cites·27 claims
- 0893US9469613B2(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideGILEAD SCIENCES INC·Filed 2015·Granted Oct 18, 2016·15 cites·23 claims
- 0992US11926592B2Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2022·Granted Mar 12, 2024·8 cites·21 claims
- 1092US10183951B2Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereofGILEAD APOLLO LLC·Filed 2017·Granted Jan 22, 2019·14 cites·10 claims
- 1191US11583531B2Solid forms of a toll-like receptor modulatorGILEAD SCIENCES INC·Filed 2020·Granted Feb 21, 2023·6 cites·29 claims
- 1290US7754731B2Potassium salt of an HIV integrase inhibitorMERCK SHARP & DOHME·Filed 2005·Granted Jul 13, 2010·26 cites·23 claims
- 1390US2025243163A1Salt of omecamtiv mecarbil and process for preparing saltCYTOKINETICS INC·Filed 2024·Application pending·0 cites
- 1484USRE49445EN-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideSIERRA ONCOLOGY INC·Filed 2020·Granted Mar 7, 2023·1 cites·62 claims
- 1583US9809559B2(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideGILEAD SCIENCES INC·Filed 2016·Granted Nov 7, 2017·3 cites·16 claims
- 1682US2023044617A1Salt of omecamtiv mecarbil and process for preparing saltCYTOKINETICS INC·Filed 2022·Application pending·0 cites
- 1781USRE48285EN-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideSIERRA ONCOLOGY INC·Filed 2018·Granted Oct 27, 2020·2 cites·26 claims
- 1880USRE50497E(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideGLAXOSMITHKLINE LLC·Filed 2023·Granted Jul 22, 2025·0 cites·47 claims
- 1980US7144915B2Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)WARNER LAMBERT CO·Filed 2003·Granted Dec 5, 2006·9 cites·46 claims
- 2076US9862728B2Crystalline forms of an antiviral compoundGILEAD SCIENCES INC·Filed 2016·Granted Jan 9, 2018·2 cites·3 claims
- 2173US11384082B2Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitorsKRONOS BIO INC·Filed 2018·Granted Jul 12, 2022·1 cites·21 claims
- 2273US9562058B2Crystalline forms of an antiviral compoundGILEAD SCIENCES INC·Filed 2014·Granted Feb 7, 2017·2 cites·13 claims
- 2372US2020079736A1Salt of omecamtiv mecarbil and process for preparing saltAMGEN INC·Filed 2019·Application pending·0 cites
- 2471US2024199550A1Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2024·Application pending·0 cites
- 2569US2018312469A1Salt of omecamtiv mecarbil and process for preparing saltAMGEN INC·Filed 2018·Application pending·0 cites
- 2666US8357798B2Process for preparing N-alkylated hydroxypyrimidinone compoundsMERCK SHARP & DOHME·Filed 2010·Granted Jan 22, 2013·1 cites·14 claims
- 2765US12122781B2Hydrates of polymorphs of 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-a]pyrazin-8-amine bis-mesylate as Syk inhibitorsKRONOS BIO INC·Filed 2022·Granted Oct 22, 2024·0 cites·19 claims
- 2865US2008287521A1Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1)PFIZER·Filed 2008·Application pending·0 cites
- 2963US2008214651A1Crystalline forms of [R-(R*, R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)PFIZER·Filed 2007·Application pending·0 cites
- 3061US2025230163A1Solid forms of hiv integrase inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3159US2023364092A1Solid forms of a toll-like receptor modulatorGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 3254US12351588B2Salt forms and solvates of Mcl-1 antagonistsAMGEN INC·Filed 2023·Granted Jul 8, 2025·0 cites·17 claims
- 3352US2025034154A1Salts and solid forms of a compound that modulates irak4GILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3448US2025289822A1Solid forms of hiv integrase inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 3546US2015299182A1Crystalline forms of (1s)-1-[5-(amino)-1,2,4-thiadiazol-3-yl]ethane-1,2-diolARRAY BIOPHARMA INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henry Morrison files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →